Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

The Binding of CD38 Therapeutics to Red Blood Cells and Platelets Subverts Depletion of Target Cells

Eric Robert Fedyk, BSc, MSc, PhD, Neeraja Idamakanti, BVSc MSc DVM, Jia Chen, BSc, MSc, PhD, Jose Estevam, BSc MSc, Vivian Hernandez, BSc PhD, Matthew Wagoner, BSc PhD, Mary Carsillo, BSc DVM PhD, Deborah Berg, RN, MSN, Kristina Allikmets, MD PhD, Gezim Lahu, BSc MSc PhD, Antonio Palumbo, MD

Blood (2019) 134 (Supplement_1): 3136.

https://doi.org/10.1182/blood-2019-128238

Published: 2019

Journal Articles

Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor?

Camillo Almici, MD, Francesca Fontana, Giovanna Piovani, Piera Balzarini, Arabella Neva, Benedetto Bruno, MD, Cristina Skert, GianLuca Rotta, Simona Fisogni, MD, Rosanna Verardi, Andrea Bianchetti, Simona Braga, Michele Malagola, MD, Nicolò Manaresi, PhD, Fabio Facchetti, Mirella Marini, MD, Domenico Russo, MD

Blood (2019) 134 (Supplement_1): 4885.

https://doi.org/10.1182/blood-2019-121879

Published: 2019

Journal Articles

Comprehensive Genomic Profiling of Chinese Acute Myeloid Leukemia (AML) with FLT3 ITD Using Ultra Deep Sequencing

Hui Kang, MD, Chen Lijuan, Yubing Xu, Fanxiang Zeng, Huan Tong, Lihua Sun, Jinwei Hu, Yongqi Yue, Gung-wei Chirn, Kai Wang, MD

Blood (2018) 132 (Supplement 1): 5262.

https://doi.org/10.1182/blood-2018-99-115631

Published: 2018

Journal Articles

A High-Throughput Workflow for the Detection, Isolation and Genomic Analysis of Single Circulating Multiple Myeloma Cells

Andrea Raspadori, PhD, Claudio Forcato, PhD, Petrini Edoardo, PhD, Francesca Marzia Papadopulos, PhD, Alberto Ferrarini, PhD, Valentina Del Monaco, PhD, Mario Terracciano, PhD, Carrie Morano, MS, Steven Gross, MS, Chiara Bolognesi, Genny Buson, PhD, Francesca Fontana, Mark Connelly, PhD, Cecilia Simonelli, MD, Gianni Medoro, PhD, Nicolò Manaresi, PhD

Blood (2018) 132 (Supplement 1): 5574.

https://doi.org/10.1182/blood-2018-99-112871

Published: 2018

Journal Articles

Characterization of a Nanobody That Binds Von Willebrand Factor and Prevents Von Willebrand Factor Cleavage By Plasmin

Lisa N. Van Der Vorm, Adam Miszta, PhD, Alicia Veninga, M.Sc., Mark Roest, PhD, Jasper A. Remijn, PhD, Dana Huskens, PhD, Bas De Laat, MD PhD

Blood (2017) 130 (Supplement 1): 1031.

https://doi.org/10.1182/blood.V130.Suppl_1.1031.1031

Published: 2017

Journal Articles

Development of Novel Human Anti-HLA-Monoclonal Antibodies for Clinical Applications Using Peripheral Blood B Cells Derived from Anti-HLA Antibody-Positive Donors

Hiroyuki Takamatsu, MD PhD, Yoshitaka Zaimoku, MD, Tatsuhiko Ozawa, PhD, Shintaro Kawai, PhD, Hidenori Tanaka, Phar.B., Hiroyuki Kishi, PhD, Atsushi Muraguchi, MD PhD, Shinji Nakao, MD PhD

Blood (2016) 128 (22): 4723.

https://doi.org/10.1182/blood.V128.22.4723.4723

Published: 2016

Journal Articles

Commonly Used Clinical Intravenous Fluid Formulations Differentially Affect Sickle Red Blood Cell Stiffness and Transit Time

Marcus A Carden, MD, Meredith Ellen Fay, BS, Yumiko Sakurai, MSc, Robert G Mannino, BS, Jordan Ciciliano, BS, Reginald Tran, BS, Wilbur A Lam, MD PhD

Blood (2015) 126 (23): 2164.

https://doi.org/10.1182/blood.V126.23.2164.2164

Published: 2015

Journal Articles

Serologic and Phenotypic Analysis of Blood Types Via Silicon Nanophotonics

James T Kirk, Kerry W Lannert, Daniel M Ratner, PhD, Jill M Johnsen, MD

Blood (2014) 124 (21): 1565.

https://doi.org/10.1182/blood.V124.21.1565.1565

Published: 2014

Journal Articles

Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL

Blood (2014) 124 (7): 1089–1098.

https://doi.org/10.1182/blood-2014-01-552067

Published: 2014

Includes: Supplemental data

Journal Articles

Old and new news in CLL: “It’s the pathway, stupid!”

Alexander Egle

Blood (2014) 124 (7): 989–990.

https://doi.org/10.1182/blood-2014-05-574145

Published: 2014

Journal Articles

Ras-Pathway Inhibition With Targeted Therapies Abrogates Self-Renewal In Acute Myelogenous Leukemia

Rebecca S. LaRue, PhD, Hanh Nguyen, Karen Sachs, Nurul Azyan Mohd Hassan, Ernesto Diaz-Flores, PhD, Susan K. Rathe, Aaron G. Sarver, Ph.D., Sean C. Bendall, Ngoc A. Ha, Miechaleen D. Diers, B.S., Garry P. Nolan, PhD, Kevin Shannon, MD, Zohar Sachs, MD, PhD, David A. Largaespada, PhD

Blood (2013) 122 (21): 819.

https://doi.org/10.1182/blood.V122.21.819.819

Published: 2013

Journal Articles

A Potential Antithrombotic Trick for an Old Drug: Quinine Inhibits the Binding of Antiphospholipid Antibody-β2-Glycoprotein I Immune Complexes to Phospholipid Bilayers in Vitro

Ervis Bezati, Xiao Xuan Wu, MD, Jacob H. Rand, MD

Blood (2012) 120 (21): 3423.

https://doi.org/10.1182/blood.V120.21.3423.3423

Published: 2012

Journal Articles

Novel Multistage Nanoparticle Drug Delivery to Ablate Leukemia Stem Cells in Their Niche.

Hongliang Zong, MD, PhD, Siddhartha Sen, PhD, Guodong Zhang, PhD, David G Gorenstein, PhD, Xuewu Liu, PhD, Mauro Ferrari, PhD, Gail J. Roboz, MD, Haifa Shen, MD, PhD, Monica L. Guzman, PhD

Blood (2012) 120 (21): 2631.

https://doi.org/10.1182/blood.V120.21.2631.2631

Published: 2012

Journal Articles

Somatic Mutation As a Mechanism of Wnt/β-Catenin Pathway Activation in CLL

Lili Wang, M.D., Ph.D., Alex K Shalek, Ph.D., Jellert Gaublomme, Michael Lawrence, Ph.D., Kristen E. Stevenson, MS, Donna S. Neuberg, ScD, Nir Hacohen, PhD, Gad Getz, Ph.D., Jennifer R. Brown, MD, PhD, Hongkun Park, Ph.D., Catherine J. Wu, MD

Blood (2012) 120 (21): 559.

https://doi.org/10.1182/blood.V120.21.559.559

Published: 2012

Journal Articles

Optical Mapping of the Myeloma Cancer Genome to Elucidate Mechanisms of Acquired Resistance to Proteasome Inhibitors.

Aditya Gupta, Jaehyup Kim, MD, Chelsea Hope, Jeff Jensen, Natalie Callander, MD, Peiman Hematti, MD, Emery H Bresnick, PhD, David C Schwartz, PhD, Fotis Asimakopoulos, MBBChir, PhD

Blood (2012) 120 (21): 2444.

https://doi.org/10.1182/blood.V120.21.2444.2444

Published: 2012

Journal Articles

Genomic Pathways and Potential Therapeutic Targets in Pediatric Burkitt Lymphoma (PBL): A Children's Oncology Group Report

Mitchell S. Cairo, MD, Nancy Day, Ph.D., Stanton Goldman, MD, Warren G. Sanger, PhD, Lauren Harrison, RN, MSN, Megan S. Lim, MD, PhD, Rodney R. Miles, MD, PhD, Sherrie L. Perkins, MD, PhD

Blood (2011) 118 (21): 1587.

https://doi.org/10.1182/blood.V118.21.1587.1587

Published: 2011

Journal Articles

Sensitivity to Wnt Pathway Inhibition in CLL Is Associated with Specific Gene Expression Signatures

Lili Wang, Alex K Shalek, Jellert Gaublomme, Nir Yosef, Jennifer R Brown, MD, PhD, Donna Neuberg, ScD, Nir Hacohen, Hongkun Park, Catherine J Wu, MD

Blood (2011) 118 (21): 801.

https://doi.org/10.1182/blood.V118.21.801.801

Published: 2011

Journal Articles

Platelet Sensing of Microenviornmental Geometry Guides Adhesion and Spreading: A Quantitative Study At the Single-Cell Level

Ashley Kita, B.S., Yumiko Sakurai, MSc, David R Myers, PhD, Ross Rounsevell, PhD, Tae Joon Seok, PhD, Kyoungsik Yu, PhD, James Huang, MD, Ming Wu, PhD, Daniel Fletcher, PhD, Wilbur Lam, MD, PhD

Blood (2011) 118 (21): 2192.

https://doi.org/10.1182/blood.V118.21.2192.2192

Published: 2011

Journal Articles

Safety and Efficacy of An Educational Program in Reducing Complications of Peripherally Inserted Central Catheters (PICCs) in Haematological Patients,

Alessandra Malato, MD, PhD, Andrea Luppino, Sr., Raffaele Pipitone, Sr., Maria Grazia Donà, Sr., Francesco Acquaviva, Sr., Francesco Fabbiano, MD

Blood (2011) 118 (21): 4219.

https://doi.org/10.1182/blood.V118.21.4219.4219

Published: 2011

Journal Articles

Consequent Iron Chelation Therapy in Patients with Low Risk Myelodysplastic Syndrome Leads to up-Regulation of .CXCL12, JAK2 and HSF2 : Possible Link Between Iron Chelation and Improvement of Erythropoiesis.

Florian Nolte, Martin Neumann, Ouidad Benlasfer, Sandra Heesch, MS, Eckhard Thiel, Uwe Platzbecker, Wolf-Karsten Hofmann

Blood (2009) 114 (22): 2787.

https://doi.org/10.1182/blood.V114.22.2787.2787

Published: 2009

NARROW

The Binding of CD38 Therapeutics to Red Blood Cells and Platelets Subverts Depletion of Target Cells

Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor?

Comprehensive Genomic Profiling of Chinese Acute Myeloid Leukemia (AML) with FLT3 ITD Using Ultra Deep Sequencing

A High-Throughput Workflow for the Detection, Isolation and Genomic Analysis of Single Circulating Multiple Myeloma Cells

Characterization of a Nanobody That Binds Von Willebrand Factor and Prevents Von Willebrand Factor Cleavage By Plasmin

Development of Novel Human Anti-HLA-Monoclonal Antibodies for Clinical Applications Using Peripheral Blood B Cells Derived from Anti-HLA Antibody-Positive Donors

Commonly Used Clinical Intravenous Fluid Formulations Differentially Affect Sickle Red Blood Cell Stiffness and Transit Time

Serologic and Phenotypic Analysis of Blood Types Via Silicon Nanophotonics

Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL

Old and new news in CLL: “It’s the pathway, stupid!”

Ras-Pathway Inhibition With Targeted Therapies Abrogates Self-Renewal In Acute Myelogenous Leukemia

A Potential Antithrombotic Trick for an Old Drug: Quinine Inhibits the Binding of Antiphospholipid Antibody-β2-Glycoprotein I Immune Complexes to Phospholipid Bilayers in Vitro

Novel Multistage Nanoparticle Drug Delivery to Ablate Leukemia Stem Cells in Their Niche.

Somatic Mutation As a Mechanism of Wnt/β-Catenin Pathway Activation in CLL

Optical Mapping of the Myeloma Cancer Genome to Elucidate Mechanisms of Acquired Resistance to Proteasome Inhibitors.

Genomic Pathways and Potential Therapeutic Targets in Pediatric Burkitt Lymphoma (PBL): A Children's Oncology Group Report

Sensitivity to Wnt Pathway Inhibition in CLL Is Associated with Specific Gene Expression Signatures

Platelet Sensing of Microenviornmental Geometry Guides Adhesion and Spreading: A Quantitative Study At the Single-Cell Level

Safety and Efficacy of An Educational Program in Reducing Complications of Peripherally Inserted Central Catheters (PICCs) in Haematological Patients,

Consequent Iron Chelation Therapy in Patients with Low Risk Myelodysplastic Syndrome Leads to up-Regulation of .CXCL12, JAK2 and HSF2 : Possible Link Between Iron Chelation and Improvement of Erythropoiesis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only